Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Outside the Lab

Outside the Lab Public health

Video: Inside The Translational Scientist

| Charlotte Barker

Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.

Outside the Lab Genetics

Gene Genie

| John Doench

Sitting Down With…John Doench, Associate Director, Genetic Perturbation Platform, Broad Institute, Cambridge, MA, USA.

Outside the Lab Public health

#Ebola

| Abraar Karan

The Ebola epidemic spurred a tremendous amount of R&D in search of vaccines and treatments – and yet it was a relatively low impact global emergency compared with malaria.

Outside the Lab Professional development

Why Doctors Make Great Entrepreneurs

| Arlen Meyers

There is an assumption that doctors and business don’t mix. But I believe physicians are ideally placed to bring new clinical innovations from a bright idea to a brand new product.

Outside the Lab Professional development

Open Your Mind

| Jackie Hunter

Open innovation is more than just the latest pharma industry buzzword. Done right, it can help overcome funding challenges and accelerate discovery across the board.

Outside the Lab Infectious diseases

Video: Inside The Translational Scientist

| Charlotte Barker

Want a lightning-fast tour of the latest issue? Take a look at our new video sneak preview.

Outside the Lab Informatics

Asking the Ultimate Question

| Michael N. Liebman

In today’s highly competitive academic world, are we losing sight of the real goal of biomedical research in our rush to secure funding and embrace the latest technologies?

Outside the Lab Professional development

Fresh-(Faced) Funding

| Robin Barr

Making grant application processes tougher can have an unexpected and dramatic effect on the demographics of applicants. Let’s not force young investigators to fall at the first hurdle.

Outside the Lab Cancer

Oncotherapy Goes Viral

| Robert Coffin

Robert Coffin tells the bench-to-bedside story of how the first FDA-approved oncolytic virotherapy, talimogene laherparepvec (T-VEC), was translated from a colleague’s cold sore to a potential global game changer.

Outside the Lab Public health

The Missing Link

| Helen Lambert

Whether you are a scientist working on a new intervention or a policy-maker trying to solve major public health problems, social and cultural factors are crucial pieces of the puzzle – ignore them at your peril. Here, I explain how social science can help.

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register